← Leaderboards
Mary J Kreek
Rockefeller University
$16,488,830
Attributed
$16,488,830
Total exposure
29
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.8M · FY2005–12$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$52,111,791 · 31
By mechanism
P60$36,238,142 · 5
R01$7,483,149 · 2
P50$5,653,825 · 2
M01$1,598,982 · 10
K05$1,038,363 · 1
P41$99,330 · 11
Top collaborators
No co-investigators on record.
Most similar at Rockefeller University
Same institution · by research overlap
- Titia De Lange$43,478,506
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectCocaineDrug AddictionMethadoneNeuropeptidesStressOpioid ReceptorOpiate AlkaloidEndogenous OpioidComorbidityAlcoholism /Alcohol AbuseHypothalamic Pituitary Adrenal AxisPharmacotherapyAddictionNeuroendocrine SystemDynorphinsCorticotropinHormonesFundingDrug MetabolismCorticotropin-Releasing HormoneGrantHeroin
Grant awards (89)
TREATMENT OF ADDICTIONS-BIOLOGICAL CORRELATES$1,141,431
P60 · FY2012 · DA · contact PI
TREATMENT OF ADDICTIONS-BIOLOGICAL CORRELATES$3,043,511
P60 · FY2011 · DA · contact PI
ALTERATIONS OF NEUROENDOCRINE STRESS RESPONSIVITY IN SPECIFIC ADDICTIVE DISEAS...$567,357
P60 · FY2011 · DA · contact PI
CLINICAL CORE$415,715
P60 · FY2011 · DA · contact PI
RESEARCH ADMINISTRATION, TRAINING, CAREER DEVELOPMENT AND MENTORING CORE$140,844
P60 · FY2011 · DA · contact PI
DISPOSITION, METABOLISM & PROCESSING OF OPIATE AGONISTS, ANTAGONISTS & OPIOIDS$26,085
P41 · FY2011 · RR · contact PI
CO2-INDUCED ANESTHESIA RESULTS IN RAPID INCREASE IN PLASMA LEVELS OF VASOPRESSIN$1,304
P41 · FY2011 · RR · contact PI
TREATMENT OF ADDICTIONS-BIOLOGICAL CORRELATES$3,056,419
P60 · FY2010 · DA · contact PI
HIV and Psychiatric Comorbidity: Selected Genetic and Epigenetic Factors$632,023
R01 · FY2010 · MH · contact PI
ALTERATIONS OF NEUROENDOCRINE STRESS RESPONSIVITY IN SPECIFIC ADDICTIVE DISEAS...$568,535
P60 · FY2010 · DA · contact PI
CLINICAL CORE$416,577
P60 · FY2010 · DA · contact PI
RESEARCH ADMINISTRATION, TRAINING, CAREER DEVELOPMENT AND MENTORING CORE$142,417
P60 · FY2010 · DA · contact PI
DISPOSITION, METABOLISM & PROCESSING OF OPIATE AGONISTS, ANTAGONISTS & OPIOIDS$16,290
P41 · FY2010 · RR · contact PI
CO2-INDUCED ANESTHESIA RESULTS IN RAPID INCREASE IN PLASMA LEVELS OF VASOPRESSIN$2,321
P41 · FY2010 · RR · contact PI
TREATMENT OF ADDICTIONS-BIOLOGICAL CORRELATES$3,004,908
P60 · FY2009 · DA · contact PI
HIV and Psychiatric Comorbidity: Selected Genetic and Epigenetic Factors$623,536
R01 · FY2009 · MH · contact PI
ALTERATIONS OF NEUROENDOCRINE STRESS RESPONSIVITY IN SPECIFIC ADDICTIVE DISEAS...$558,442
P60 · FY2009 · DA · contact PI
CLINICAL CORE$409,187
P60 · FY2009 · DA · contact PI
RESEARCH ADMINISTRATION, TRAINING, CAREER DEVELOPMENT AND MENTORING CORE$139,790
P60 · FY2009 · DA · contact PI
DISPOSITION, METABOLISM & PROCESSING OF OPIATE AGONISTS, ANTAGONISTS & OPIOIDS$14,228
P41 · FY2009 · RR · contact PI
CO2-INDUCED ANESTHESIA RESULTS IN RAPID INCREASE IN PLASMA LEVELS OF VASOPRESSIN$2,367
P41 · FY2009 · RR · contact PI
TREATMENT OF ADDICTIONS-BIOLOGICAL CORRELATES$2,912,467
P60 · FY2008 · DA · contact PI
HIV and Psychiatric Comorbidity: Selected Genetic and Epigenetic Factors$605,946
R01 · FY2008 · MH · contact PI
ALTERATIONS OF NEUROENDOCRINE STRESS RESPONSIVITY IN SPECIFIC ADDICTIVE DISEAS...$540,699
P60 · FY2008 · DA · contact PI
CLINICAL CORE$396,177
P60 · FY2008 · DA · contact PI
RESEARCH ADMINISTRATION, TRAINING, CAREER DEVELOPMENT AND MENTORING CORE$135,702
P60 · FY2008 · DA · contact PI
DISPOSITION, METABOLISM & PROCESSING OF OPIATE AGONISTS, ANTAGONISTS & OPIOIDS$6,639
P41 · FY2008 · RR · contact PI
TREATMENT OF ADDICTIONS-BIOLOGICAL CORRELATES$2,698,607
P60 · FY2007 · DA · contact PI
HIV and Psychiatric Comorbidity: Selected Genetic and Epigenetic Factors$561,991
R01 · FY2007 · MH · contact PI
ALTERATIONS OF NEUROENDOCRINE STRESS RESPONSIVITY IN SPECIFIC ADDICTIVE DISEAS...$474,572
P60 · FY2007 · DA · contact PI
CLINICAL CORE$343,768
P60 · FY2007 · DA · contact PI
RESEARCH ADMINISTRATION, TRAINING, CAREER DEVELOPMENT AND MENTORING CORE$342,011
P60 · FY2007 · DA · contact PI
Addictive Drugs-Pharmacology & Physiology$136,080
K05 · FY2007 · DA · contact PI
DISPOSITION, METABOLISM & PROCESSING OF OPIATE AGONISTS, ANTAGONISTS & OPIOIDS$7,514
P41 · FY2007 · RR · contact PI
TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES$3,048,429
P60 · FY2006 · DA · contact PI
HIV and Psychiatric Comorbidity: Selected Genetic and Epigenetic Factors$561,925
R01 · FY2006 · MH · contact PI
Addictive Drugs-Pharmacology & Physiology$129,470
K05 · FY2006 · DA · contact PI
DISPOSITION, METABOLISM & PROCESSING OF OPIATE AGONISTS, ANTAGONISTS & OPIOIDS$4,933
P41 · FY2006 · RR · contact PI
TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES$3,025,003
P60 · FY2005 · DA
PHYSIOLOGIC EFFECTS OF OPIOID PEPTIDES &THEIR CONGENERS: DYNORPHIN A PEPTIDES$204,972
M01 · FY2005 · RR
CORTICOTROPIN RELEASING FACTOR EFFECTS AND POSSIBLE ROLE IN ADDICTIVE DISEASES$181,830
M01 · FY2005 · RR
STUDIES OF ENDOCRINE FUNCTION IN PTS WITH ADDICTIVE DISEASES &LIVER DISEASE$137,860
M01 · FY2005 · RR
Addictive Drugs-Pharmacology &Physiology$129,470
K05 · FY2005 · DA
HUMAN GENETIC CORRELATES OF THE ADDICTIVE DISEASES$109,760
M01 · FY2005 · RR
STUDIES OF LONG-ACTING OPIOID METABOLISM DISPOSITION, DRUG INTERACTIONS, EFFECTS$95,874
M01 · FY2005 · RR
TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES$74,962
P60 · FY2005 · DA
DISPOSITION, METABOLISM &PROCESSING OF OPIATE AGONISTS, ANTAGONISTS &OPIOIDS$4,761
P41 · FY2005 · RR
TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES$2,936,379
P60 · FY2004 · DA
Physiologic Effects of Opioid Peptides &Their Congeners: Dynorphin A Peptides$412,491
M01 · FY2004 · RR
Studies of Endocrine Function in Pts With Addictive Diseases &Liver Disease$166,874
M01 · FY2004 · RR
Addictive Drugs-Pharmacology &Physiology$129,470
K05 · FY2004 · DA
Human Genetic Correlates of the Addictive Diseases$114,501
M01 · FY2004 · RR
Studies of Long-Acting Opioid Metabolism Disposition, Drug Interactions, Effects$105,109
M01 · FY2004 · RR
Corticotropin Releasing Factor Effects and Possible Role In Addictive Diseases$69,711
M01 · FY2004 · RR
DISPOSITION, METABOLISM &PROCESSING OF OPIATE AGONISTS$4,689
P41 · FY2004 · RR
TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES$2,856,886
P60 · FY2003 · DA
ADDICTIONS: GENOTYPES, POLYMOPHISMS, AND FUNCTION$1,139,630
R01 · FY2003 · DA
TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES$465,721
P60 · FY2003 · DA
ADDICTIONS: GENOTYPES, POLYMOPHISMS, AND FUNCTION$168,050
R01 · FY2003 · DA
Addictive Drugs-Pharmacology &Physiology$128,012
K05 · FY2003 · DA
TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES$2,381,626
P60 · FY2002 · DA
ADDICTIONS: GENOTYPES, POLYMOPHISMS, AND FUNCTION$1,106,441
R01 · FY2002 · DA
ADDICTIVE DRUGS--PHARMACOLOGY AND PHYSIOLOGY$129,155
K05 · FY2002 · DA
HUMAN GENETIC CORRELATES OF ADDICTIVE DISEASE$0
M01 · FY2002 · RR
NEUROENDOCRINE EFFECTS OF OPIATES AND COCAINE$0
P60 · FY2002 · DA
PHYSIOLOGIC EFFECTS OF OPIOID PEPTIDES AND THEIR CONGENERS--DYNORPHIN A PEPTIDES$0
M01 · FY2002 · RR
LONG ACTING OPIOID METABOLISM, DISPOSITION, DRUG INTERACTION, AND EFFECTS$0
M01 · FY2002 · RR
CORTICOTROPIN RELEASING FACTOR (HCRF)--POSSIBLE ROLE IN ADDICTIVE DISORDERS$0
M01 · FY2002 · RR
ENDOCRINE FUNCTION IN PATIENTS WITH ADDICTIVE DISEASES AND LIVER DISEASE$0
M01 · FY2002 · RR
TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES$2,524,650
P50 · FY2001 · DA
ADDICTIONS: GENOTYPES, POLYMOPHISMS, AND FUNCTION$1,057,197
R01 · FY2001 · DA
NEUROENDOCRINE EFFECTS OF ADDICTIVE DRUGS--ENDOGENOUS OPIOIDS &STRESS RESPONSE$268,419
P50 · FY2001 · DA
ADDICTIVE DRUGS--PHARMACOLOGY AND PHYSIOLOGY$128,669
K05 · FY2001 · DA
LONG ACTING OPIOID METABOLISM, DISPOSITION, DRUG INTERACTION, AND EFFECTS$0
M01 · FY2001 · RR
CORTICOTROPIN RELEASING FACTOR (HCRF)--POSSIBLE ROLE IN ADDICTIVE DISORDERS$0
M01 · FY2001 · RR
ENDOCRINE FUNCTION IN PATIENTS WITH ADDICTIVE DISEASES AND LIVER DISEASE$0
M01 · FY2001 · RR
DISPOSITION, METABOLISM &PROCESSING OF OPIATE AGONISTS, ANTAGONISTS &OPIOIDS$0
P41 · FY2001 · RR
PHYSIOLOGIC EFFECTS OF OPIOID PEPTIDES AND THEIR CONGENERS--DYNORPHIN A PEPTIDES$0
M01 · FY2001 · RR
HUMAN GENETIC CORRELATES OF ADDICTIVE DISEASE$0
M01 · FY2001 · RR
TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES$2,451,962
P50 · FY2000 · DA
ADDICTIONS: GENOTYPES, POLYMOPHISMS, AND FUNCTION$1,026,410
R01 · FY2000 · DA
NEUROENDOCRINE EFFECTS OF ADDICTIVE DRUGS--ENDOGENOUS OPIOIDS &STRESS RESPONSE$408,794
P50 · FY2000 · DA
ADDICTIVE DRUGS--PHARMACOLOGY AND PHYSIOLOGY$128,037
K05 · FY2000 · DA
DISPOSITION, METABOLISM &PROCESSING OF OPIATE AGONISTS, ANTAGONISTS &OPIOIDS$8,199
P41 · FY2000 · RR
EFFECTS OF OPIOID PEPTIDES/CONGENERS--DYNORPHIN A$0
M01 · FY2000 · RR
HUMAN GENETIC CORRELATES OF ADDICTIVE DISEASE$0
M01 · FY2000 · RR
LONG ACTING OPIOID METABOLISM, DISPOSITION, DRUG INTERACTION, AND EFFECTS$0
M01 · FY2000 · RR
CORTICOTROPIN RELEASING FACTOR (HCRF)--POSSIBLE ROLE IN ADDICTIVE DISORDERS$0
M01 · FY2000 · RR
ENDOCRINE FUNCTION IN PATIENTS WITH ADDICTIVE DISEASES AND LIVER DISEASE$0
M01 · FY2000 · RR